Kanwal et al. reported an increased risk of HCC (aHR 7.62 compared to patients without NAFLD) in 296 707 patients with NAFLD (diagnosed using consecutively increased alanine aminotransferase levels). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.